Cargando…

An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses

Detalles Bibliográficos
Autores principales: Prokopez, Cintia R., Vallejos, Miguel, Lopredo, Lorena S., Sfriso, Luciano E., Chiapella, Luciana C., Arce, Claudio, Corral, Ricardo M., Cuesta, Manuel J., Farinola, Romina, Alomo, Martín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220941/
https://www.ncbi.nlm.nih.gov/pubmed/34215466
http://dx.doi.org/10.1016/j.schres.2021.06.019
_version_ 1783711239762870272
author Prokopez, Cintia R.
Vallejos, Miguel
Lopredo, Lorena S.
Sfriso, Luciano E.
Chiapella, Luciana C.
Arce, Claudio
Corral, Ricardo M.
Cuesta, Manuel J.
Farinola, Romina
Alomo, Martín
author_facet Prokopez, Cintia R.
Vallejos, Miguel
Lopredo, Lorena S.
Sfriso, Luciano E.
Chiapella, Luciana C.
Arce, Claudio
Corral, Ricardo M.
Cuesta, Manuel J.
Farinola, Romina
Alomo, Martín
author_sort Prokopez, Cintia R.
collection PubMed
description
format Online
Article
Text
id pubmed-8220941
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-82209412021-06-23 An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses Prokopez, Cintia R. Vallejos, Miguel Lopredo, Lorena S. Sfriso, Luciano E. Chiapella, Luciana C. Arce, Claudio Corral, Ricardo M. Cuesta, Manuel J. Farinola, Romina Alomo, Martín Schizophr Res Letter to the Editor Elsevier B.V. 2021-07 2021-06-23 /pmc/articles/PMC8220941/ /pubmed/34215466 http://dx.doi.org/10.1016/j.schres.2021.06.019 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Prokopez, Cintia R.
Vallejos, Miguel
Lopredo, Lorena S.
Sfriso, Luciano E.
Chiapella, Luciana C.
Arce, Claudio
Corral, Ricardo M.
Cuesta, Manuel J.
Farinola, Romina
Alomo, Martín
An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses
title An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses
title_full An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses
title_fullStr An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses
title_full_unstemmed An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses
title_short An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses
title_sort analysis of the possible protective effect of antipsychotics for sars-cov-2 in patients under treatment for severe mental illnesses
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220941/
https://www.ncbi.nlm.nih.gov/pubmed/34215466
http://dx.doi.org/10.1016/j.schres.2021.06.019
work_keys_str_mv AT prokopezcintiar ananalysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT vallejosmiguel ananalysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT lopredolorenas ananalysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT sfrisolucianoe ananalysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT chiapellalucianac ananalysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT arceclaudio ananalysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT corralricardom ananalysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT cuestamanuelj ananalysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT farinolaromina ananalysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT alomomartin ananalysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT prokopezcintiar analysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT vallejosmiguel analysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT lopredolorenas analysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT sfrisolucianoe analysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT chiapellalucianac analysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT arceclaudio analysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT corralricardom analysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT cuestamanuelj analysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT farinolaromina analysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses
AT alomomartin analysisofthepossibleprotectiveeffectofantipsychoticsforsarscov2inpatientsundertreatmentforseverementalillnesses